Lenalid 10 Mg(Lenalidomide)

✅ Key Benefits

• Enhances immune response via T cell and NK cell activation

• Reduces angiogenesis, depriving tumors of blood supply

• Proven to improve progression-free and overall survival in clinical trials

• Oral once-daily dosing improves convenience and adherence

• Versatile use in multiple hematologic cancer indications

🎯 How to Use

• Take one 10 mg capsule daily, according to physician instructions

• Swallow each capsule whole with water, with or without food

• Treatment cycles typically follow a 21-days on, 7-days off regimen

• Regular monitoring: CBC with differential, renal and liver function tests

• Dosing modifications recommended for renal insufficiency or adverse effects

⚠️ Precautions

• Prescription-only; must be supervised by an oncology specialist

• High risk of blood clots—prophylaxis may be required

• Hematologic toxicity: neutropenia, anemia, thrombocytopenia—frequent CBC monitoring needed

• Teratogenic risk: not for use during pregnancy; adhere to REMS or similar risk management guidelines

• All concomitant medications should be reviewed for drug interactions

🤕 Possible Side Effects

• Common: Fatigue, diarrhea, constipation, rash

• Hematologic: Neutropenia, thrombocytopenia, anemia

• Thromboembolic: Deep vein thrombosis, pulmonary embolism

• Other: Headache, pruritus, peripheral edema

• Serious: Severe myelosuppression, secondary malignancies—seek prompt medical attention if noticed

❓ Frequently Asked Questions (FAQs)

Q. Who is Lenalid prescribed for?
A. It’s used for multiple myeloma (initial or maintenance therapy), transfusion-dependent low- to intermediate-risk MDS with 5q deletion, or relapsed mantle cell lymphoma.

Q. What’s a typical treatment schedule?
A. Usually 21 days on medication followed by 7 days off; schedules may vary based on indication and response.

Q. How do you reduce blood clot risk?
A. Prophylactic anticoagulants (aspirin or low-molecular-weight heparin) and close monitoring help prevent thromboembolic events.

Q. Is dose adjustment needed for kidney problems?
A. Yes—dosing is frequently reduced in patients with impaired renal function to ensure safety.